NASDAQ:NSPR - InspireMD Stock Price, News & Analysis

$2.88
+0.33 (+12.94 %)
(As of 08/23/2019 04:53 AM ET)
Today's Range
$2.50
Now: $2.88
$2.97
50-Day Range
$1.99
MA: $2.92
$3.57
52-Week Range
$1.90
Now: $2.88
$15.35
Volume124,200 shs
Average Volume139,270 shs
Market Capitalization$3.91 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NSPR
CUSIPN/A
CIKN/A
Phone972 3 6917691

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees43
Market Cap$3.91 million
Next Earnings Date11/5/2019 (Estimated)
OptionableNot Optionable

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.


InspireMD (NASDAQ:NSPR) Frequently Asked Questions

What is InspireMD's stock symbol?

InspireMD trades on the NASDAQ under the ticker symbol "NSPR."

When is InspireMD's next earnings date?

InspireMD is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for InspireMD.

What is the consensus analysts' recommendation for InspireMD?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for InspireMD.

Has InspireMD been receiving favorable news coverage?

Media coverage about NSPR stock has been trending positive on Friday, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. InspireMD earned a media sentiment score of 2.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the company's share price in the next several days. View News Stories for InspireMD.

Who are some of InspireMD's key competitors?

What other stocks do shareholders of InspireMD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Catabasis Pharmaceuticals (CATB), Beyond Meat (BYND), Bridgeline Digital (BLIN), BioScrip (BIOS), Baidu (BIDU), Bed Bath & Beyond (BBBY), Avinger (AVGR), AVEO Pharmaceuticals (AVEO), Achaogen (AKAO) and Aceto (ACET).

Who are InspireMD's key executives?

InspireMD's management team includes the folowing people:
  • Dr. James J. Barry, Pres, CEO & Director (Age 60)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
  • Mr. Benzi Spector, Head of R&D and Operations
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 72)

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $2.88.

How big of a company is InspireMD?

InspireMD has a market capitalization of $3.91 million. InspireMD employs 43 workers across the globe.View Additional Information About InspireMD.

What is InspireMD's official website?

The official website for InspireMD is http://www.inspiremd.com/.

How can I contact InspireMD?

The company can be reached via phone at 972 3 6917691.


MarketBeat Community Rating for InspireMD (NASDAQ NSPR)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  16
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe NSPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/23/2019 by MarketBeat.com Staff

Featured Article: What is a Stop Order?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel